Sponsor:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Request for Information (RFI): Inviting Scientific Interest in Geroscience Summit III
National Institute on Aging - Notice of Intent to Publish a Funding Opportunity Announcement for Alzheimer Centers for Discovery of New Medicines (U54 - Clinical Trial Not Allowed)
National Institute on Aging - NIAID Interest in Administrative Supplements to Address the Research Needed to Develop a Universal Influenza Vaccine
National Institute of Allergy and Infectious Diseases - Notice of Change to the NIAID Specific Areas of Research Interest for PA-18-722 "Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)"
National Institute of Allergy and Infectious Diseases
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Behavioral and Social Science Research - Notice of Change to the NIAID Specific Areas of Research Interest for PA-18-723 "Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)"
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Behavioral and Social Science Research - PRE-SOLICITATION NOTICE: NIAID Virology Quality Assurance (VQA) Program, NIAID-DAIDS-NIHAI201700103
National Institute of Allergy and Infectious Diseases - Notice of Correction to Award Information in PAR-18-246 Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)"
National Cancer Institute - Notice of Correction to Award Information in PAR-18-247 Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)"
National Cancer Institute - Notice of Change in Eligible Organizations in PA-18-748 Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed)" to Allow Foreign Institutions.
National Cancer Institute - Presolicitation Notice: Request for Proposals (RFP) N01CN77019-18 "PREVENT Cancer Preclinical Drug Development Program: Preclinical Services for Biopharmaceutical Product Development and Manufacturing, Toxicology and Pharmacology Testing"
National Cancer Institute - Update in Funds Available and Anticipated Number of Awards , Award Budget and Award Project Period Sections of RFA-FD-08-018 - Development of a virtual bioequivalence trial simulation platform that integrates population pharmacokinetic modeling algorithms into physiologically-based pharmacokinetic models
Food and Drug Administration - Update in Funds Application Due Date(s) & Expiration Date Sections of RFA-FD-08-019 - Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems (U01)
Food and Drug Administration - Notice of NICHD Participation in NOT-AG-18-008 "Alzheimer's Disease and its related Dementias (AD/ADRD)-focused Administrative supplements for NIH grants that are not focused on Alzheimer's disease"
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Intent to Publish a Funding Opportunity Announcement for Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3)
National Heart, Lung, and Blood Institute - Registration Process Changes in SAM.gov
Agency for Healthcare Research and Quality - REMINDER - Expiring Funds Alert to AHRQ Grant Recipients who Received Multi-Year Funded Awards
Agency for Healthcare Research and Quality - Salary Limitation on AHRQ FY2018 Grants, Cooperative Agreements, and Contracts
Agency for Healthcare Research and Quality - NINDS Announces Modifications to Special Council Review Policy
National Institute of Neurological Disorders and Stroke - Notice to Extend the Expiration Date and Change Receipt Dates for PAR-16-458 "NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32)"
National Institute of Neurological Disorders and Stroke - Notice of Availability of Administrative Supplements for Secondary Analysis of Existing Datasets within the Rare Diseases Clinical Research Network (RDCRN) to Explore Outcomes Relevant to Rare Diseases
National Center for Advancing Translational Sciences
National Heart, Lung, and Blood Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke - Notice of Change to Application Due Date to PAR-18-244 "Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01)"
National Center for Advancing Translational Sciences - Notice of Change of Application Due Date to PAR-18-245 "Limited Competition: Exploratory CTSA Collaborative Innovation Awards (R21)"
National Center for Advancing Translational Sciences
Requests for Applications
- Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Optional)
- Small Research Grant Program for the Next Generation of Researchers in Basic Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
- Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
- Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required)
National Cancer Institute
- SBIR E-learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
- Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act
Food and Drug Administration
- Strengthen Regulatory Systems to Ensure the Safety and Quality of Food and Medical Products (U01)
Food and Drug Administration
- T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
- NIH Director's Pioneer Award (DP1 - Clinical Trial Optional)
Office of Strategic Coordination (Common Fund)
Program Announcements
- Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 - Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu